Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Is There a Link between the Lipopolysaccharide of Helicobacter pylori Gastric MALT Lymphoma Associated Strains and Lymphoma Pathogenesis?

  • Philippe Lehours ,

    philippe.lehours@labhel.u-bordeaux2.fr

    Affiliations INSERM, U853, Bordeaux, France, Université Victor Segalen Bordeaux 2, Bordeaux, France, CHU Bordeaux, National Reference Center for Helicobacters and Campylobacters, Pellegrin Hospital, Bordeaux, France

  • Zongli Zheng,

    Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institute Stockholm, Sweden

  • Anna Skoglund,

    Affiliations Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden, Swedish Institute for Infectious Disease Control, Solna, Sweden

  • Francis Mégraud,

    Affiliations INSERM, U853, Bordeaux, France, Université Victor Segalen Bordeaux 2, Bordeaux, France, CHU Bordeaux, National Reference Center for Helicobacters and Campylobacters, Pellegrin Hospital, Bordeaux, France

  • Lars Engstrand

    Affiliations Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden, Swedish Institute for Infectious Disease Control, Solna, Sweden

Abstract

The aim of this study was to investigate the Lewis antigen expression in Helicobacter pylori gastric MALT lymphoma associated strains in comparison to chronic gastritis only strains. Forty MALT strains (19 cagPAI (−) and 21 cagPAI (+)) and 39 cagPAI frequency-matched gastritis strains (17 cagPAI (−) and 22 cagPAI (+)) were included in this study. The lipopolyssacharide for each strain was extracted using a hot phenol method and the expression of Lex and Ley were investigated using Western Blot. The data were analyzed according to the strains' cagPAI status and vacA genotype. Lex was identified in 21 (52.5%) MALT strains and 29 (74.3%) gastritis strains. Ley was identified in 30 (75%) MALT strains and 31 (79.5%) gastritis strains. There was an association between cagPAI positivity and Lex expression among MALT strains (p<0.0001), but not in gastritis strains (p = 0.64). Among cagPAI (−) strains, isolates expressing solely Ley were associated with MALT with an odds ratio of 64.2 (95% CI 4.9–841.0) when compared to strains expressing both Lex and Ley. vacA genotypes did not modify the association between Lewis antigen expression and disease status. In conclusion, cagPAI (−) MALT strains have a particular Lewis antigen profile which could represent an adaptive mechanism to the host response or participate in MALT lymphomagenesis.

Introduction

Helicobacter pylori was the first bacterium classified as a type I carcinogen (maximum level) [1]. Since its discovery, many research projects have focused on virulence factors or genetic markers but few studies have included H. pylori strains associated with gastric mucosa associated lymphoid tissue (MALT) lymphoma [2][5]. Gastric lymphoma is considered to be the classic lymphoma of MALT-type of the digestive tract [6]. It is a B lymphoma with a very unusual pathogenesis and evolution which evolves very progressively and stays localized in the stomach for a long time. The development of the lymphoma is directly linked to the H. pylori infection although it is not known why this evolution occurs in only a very small number of infected subjects. A large number of molecular events participating in the lymphomagenesis of MALT lymphomas have already been described, in which a chronic antigenic stimulation plays a pivotal role. Moreover, as the incidence of MALT lymphoma may correlate with different inflammatory cytokines and gene polymorphisms, the role of the host immune response has not been clearly defined yet [7].

The role of H. pylori strains on B-cell proliferation in low-grade MALT lymphoma is well established [8][10]. However, some questions remained unanswered. What is the nature of the H. pylori antigens recognized by lymphocytes? How does this recognition occur? Dendritic cells (DC) could play a role in antigen recognition and in inflammatory response in this disease. Indeed, the response of DC to a specific organism depends on the pathways activated in response to the microbial agent and to the cells present in the environment [11]. H. pylori lipopolyssacharide (LPS) is one of the key effectors of Toll Like Receptor-4 and it has been shown that the nature of the Lewis-type antigens expressed on the surface of the LPS of H. pylori determines the interaction with DC via the recognition by a C-type lectin called DC-SIGN at the surface of DC [12]. It has been also suggested that interaction with DC-SIGN could influence the pro-inflammatory response. Lewis negative strains escape binding to DC and induce a strong Th1-cell response. In contrast, H. pylori strains that express Lex and/or Ley can bind to DC-SIGN and enhance the production of IL-10 which promotes a Th2-cell response and blocking of Th1-cell activation.

In the context of gastric MALT lymphoma, the chronicity of H. pylori infection is believed to be crucial [6]. According to Suarez et al., the chronic microbial antigenic stimulation observed during persisting H. pylori infection constitutes an antigenic source in autoimmunity which leads to sustained B-cell stimulation, thus favoring lymphoid transformation and lymphoma development [13]. Therefore, in this chronic disease a molecular mimicry, which implies the expression of microbial pathogen motifs shared with the host, could be mandatory to favor H. pylori persistence. Lewis determinants resemble autoantigens because of the molecular mimicry with the fucosylated Lewis antigens [14] expressed by the mucosal chief and parietal cells of the gastric glands as well as on the surface and foveolar epithelia [15].

Lex and Ley (type 2 carbohydrates) are the dominant Lewis antigens in H. pylori LPS expressed by 80–90% of clinical isolates whereas Lea, Leb, H-1 (type 1 carbohydrates), Lewis c, and sialyl Lex are rarely expressed (less than 5%) [16], [17]. Three fucosyltransferases FutA, FutB and FutC are involved in Lewis antigen synthesis. FutA and FutB which have an α1,3 and/or α1,4-fucosyltransferase activity are required for Lex or Lea antigen synthesis, respectively. FutC which has an α1,2 fucosyltransferase activity transfers an additional fucose to produce Ley or Leb antigens. The three corresponding genes, ie, futA (HP0379), futB (HP0651) and futC (HP0093-94), contain poly-C tracts at the 5′ end that regulates their expression by a slipped strand mispairing mechanism [18].

The Lex and Ley antigens expressed on the LPS of H. pylori gastric MALT lymphoma strains has not yet been investigated. Therefore, the aim of this project was to study these LPS structures of H. pylori gastric MALT lymphoma strains in comparison to strains solely associated with chronic gastritis.

Results

Description of the cag pathogenicity island (cagPAI) status and vacuolating cytotoxin gene A (vacA) genotypes of the strains included in the present study

As indicated in material and methods, 40 MALT strains (19 cagPAI (−) and 21 cagPAI (+)) and 39 gastritis strains (17 cagPAI (−) and 22 cagPAI (+)) were included in this study.

The 39 gastritis strains were classified according to the signal region as either s1 or s2 or according to the middle region as m1 or m2 of the vacA gene. The distribution of the different alleles, s1m1, s1m2 and s2m2 of the gastritis strains were 16 (41%), 15 (38.5%) and 8 (20.5%), respectively.

As previously determined [4], the different vacA alleles for MALT strains were 11 s1m1 (27.5%), 12 s1m2 (30%) and 17 s2m2 (42.5%).

Distribution of the Lex and Ley antigens among the strains according to the disease status and virulence factors

Lex was identified in 21 MALT strains (52.5%) and Ley in 30 strains (75%). Lex was identified in 29 gastritis strains (74.3%) and Ley in 31 strains (79.5%). Depending on the Lewis antigens expressed, the strains were divided into four groups. Five gastritis strains (12.8%) and 5 MALT strains (12.5%) were Lex/y negative. Three gastritis strains (7.7%) and 5 MALT strains (12.5%) only expressed Lex. Five gastritis strains (12.8%) and 14 MALT strains (35%) solely expressed Ley. Finally, 26 gastritis strains (66.7%) and 16 MALT strains (40%) were both Lex/y positive.

There was a significant association between cagPAI status and Lex expression among MALT strains (p<0.0001), but not in gastritis strains (p = 0.64, NS).

There was a significant interaction between Lewis antigens and cagPAI status in relation to the disease status (P value for interaction = 0.028), therefore we stratified the analysis.

Among cagPAI negative strains, Lex were expressed in 12 gastritis strains (70.6%) and only in 3 MALT strains (15.8%); and Ley in 13 gastritis strains (76.5%) and in 13 MALT strains (68.4%). In a regression model, cagPAI negative strains expressing solely Ley were associated with MALT with an odds ratio (OR) of 64.2 with 95% confidence intervals (95% CIs) 4.9–841.0 when compared to Lex/y positive strains (Table 1).

thumbnail
Table 1. Distribution of the Lewis phenotypes among gastritis and MALT lymphoma strains of Helicobacter pylori according to the cagPAI status.

https://doi.org/10.1371/journal.pone.0007297.t001

Among cagPAI positive strains, Lex were expressed in 17 gastritis strains (77.3%) and 18 MALT strains (85.7%); and Ley in 18 gastritis strains (81.8%) and 17 MALT strains (81.0%). cagPAI positive strains expressing solely Ley were not associated with MALT when compared to Lex/y positive strains (OR 0.4; 95% CI 0.03–5.8) (Table 1).

vacA genotypes did not modify the association between Lewis antigens and disease status.

Sequencing of futA and futB for Lex/y negative strains

The LPS extraction was verified on SDS/PAGE gels after silver staining (data not shown) for the Lex/y negative strains: 5 gastritis strains (3 cagPAI (−) and 2 cagPAI (+)) (G152, G171, G541, G32 andG447) and 5 MALT lymphoma strains (3 cagPAI (−) and 1 cagPAI (+)) (M30, M33, M40 and M48). The futA and futB genes were then sequenced. According to the number of C repeats that regulates the on/off status of the genes, 9 strains were futA “off” and one strain futA “on” (M54), 8 strains were futB “off” and 2 strains futB “on” (G447, G541). To summarize, a total of 7 strains were “off” for both the futA and futB genes (ie, M30, M33, M40, M48, G152; G171 and G32), one strain was futA “on” only (M54) and in two strains only futB was “on” (ie, G541 and G447) (Table 2). The number of C repeats varied between 8 to 13 for futA and from 8 to 11 for futB. The first 91 bp of the 5′ part of the genes which contains the CC repeats, as well as the deduced amino acid sequenced, are shown in Table 2.

thumbnail
Table 2. Signal-sequence coding region of the futA and futB genes and deduced amino acid sequences of 10 Lex/y negative Helicobacter pylori strains.

https://doi.org/10.1371/journal.pone.0007297.t002

Discussion

The LPS expressed by H. pylori strains has been suggested to be important for gastric colonization, adherence and immune evasion through a “camouflage” mechanism in order to escape the host immune response [19]. The influence of Lewis antigens is also believed to participate in the polarization of the Th1/Th2 inflammatory response. Lewis antigens expressed by H. pylori MALT strains could play a key role in the physiopathology of the disease. We previously described the main virulence factors expressed by gastric MALT lymphoma strains except the Lewis antigens [4]. Therefore, in the present study, the Lewis antigen expression was compared between H. pylori MALT strains and the chronic gastritis strains. The gastritis strains were selected on the presence or absence of the cagPAI in order to match the gastric MALT lymphoma strains and to constitute two comparable groups.

Most of the strains (59/69, 85.5%) included in the present study expressed at least one Lewis antigen (Lex and/or Ley) which is in line with previous reports [17]. Although it is well known that a combination of all several methods (serodot, Western blotting and enzyme-linked immunosorbent assay) may allow a more accurate assessment of Le expression [20], only 10 double Lex/y negative strains were identified and mainly among cagPAI negative strains (60%) as already described. Concerning these double negative strains and according to the number of C repeats, the correlation with the futA and futB sequences was not perfect. Indeed, because 3 of these 10 strains were “on” for futA or futB, we cannot exclude that they do not express some of the other less common Lewis antigens [16].

The Lewis antigen patterns were then analyzed according to the cagPAI status and vacA genotypes of the strains. This is an issue that has been extensively discussed previously. A first study published by Wirth et al. showed that Lex expression in H. pylori was correlated with its CagA status [21]. Some studies suggest that such a correlation does not exist [22] or that an inverse correlation exists between CagA positive strains and Lex and Ley expression [23]. Broutet et al. studied the LPS of 155 isolates from atrophic gastritis patients, and identified two main clusters of strains, those which were CagA positive and double Lex/y positive, and a second cluster comprised of CagA negative and solely Ley positive or double Lex/y negative [24]. The authors also showed a correlation with vacA genotypes. However, more recently, Skoglund et al., considering only Le antigen expression, were not able to confirm such a correlation for atrophic gastritis isolates [25]. Nevertheless, CagA positive isolates are believed to be more aggressive and more exposed to the immune system. Therefore, a camouflage by an efficient mimicry process could help them to persist in the stomach of their host. A similar association was found in the present study for Lex and cagPAI positive gastric MALT lymphoma strains. Indeed, the proinflammatory properties of cagPAI positive gastric MALT lymphoma strains have been previously proven using the AGS cell model (most cagPAI positive MALT lymphoma strains harbored a functional cagPAI) but no important proinflammatory factors could be identified in cagPAI negative H. pylori MALT strains [26]. According to Moran, all of the discrepancies between Lewis antigens expression and cagPAI status are believed to be due to the adaptation of H. pylori strains to different populations [19], [27]. However, in contrary to the study of Broutet el al., the present study did not identify a correlation between Lewis antigens and vacA genotypes [24].

Concerning the disease status among cagPAI negative MALT strains, a significant association was found with Ley. Although we were not able to quantify the amount of Ley expressed by the strains, the Ley bands obtained by Western Blot were very intense (data not shown). It has been suggested that a high expression of Ley could mask the Lex epitopes [18]. The activity of futC in Ley synthesis is very critical. Indeed, strains that have a relatively high level of futC activity could transform nearly all of the Lex to Ley giving rise to a phenotype expressing solely Ley, whereas relatively lower activity is believed to be responsible for a simultaneous Lex and Ley phenotype. Like futA and futB, futC is regulated by a slipped-strand mispairing mechanism through a polyC tract as well as an imperfect TAA repeat in the mid-region of futC [28]. The futC expression could also be influenced by translational frameshift, transcriptional regulation of certain genes as well as deletion in the promoter region. Therefore, we believe that the high Ley expression in cagPAI negative MALT strains should be studied more extensively on a genetic basis.

What could the role of Ley be in cagPAI negative MALT strains? During H. pylori chronic infection, Ley expression has been implicated in the pathogenesis of atrophic gastritis through the induction of autoreactive antibodies against the gastric mucosa [19]. For example, such antibodies have been found in patients with atrophic gastritis and gastric cancer. Skoglund et al. recently published a paper in which they showed that the HPAG1 strain (which is a Ley positive strain) was able to switch in vivo to both Lex and Ley expression, while the same strain in a mouse model of gastric atrophy remained to exclusively express Ley. The authors concluded that the switch in Lewis antigen expression was linked to different gastric environments, and possibly gastric pH. However, the authors were not able to reproduce this phenomenon in vitro by using culture broth at different pH [25]. Indeed, it has been shown that futC transcription can be regulated by environmental factors such as gastric acid and host immunity [29]. The study of Skoglund et al. indicates that Lewis expression at the time of isolation can be considered as a “snap-shot” of a strain at a particular time of the disease status/development reflecting the bacterial adaptation to in vivo conditions. Therefore, the higher expression of Ley in cagPAI negative MALT strains identified in the present study raises the question of the presence of a component of atrophy in patients infected by these types of strains. This particular point has been suggested in long-term infected BALB/c mice [30], [31]. The presence of auto anti Ley antibodies in the physiopathology of this disease should also be evaluated.

In the context of gastric MALT lymphoma, intra Th lymphocytes are essentially Th0, and Greiner et al. showed the important role of cytokines produced by Th2 lymphocytes (IL-4, IL-10) [32]. Similarly, animal models for MALT lymphoma (BALB/c mouse) showed a Th2 type response [31], [33]. Because most of the MALT strains expressed at least one Lewis antigen, they should be able to polarize a Th2 inflammatory response and to address this major point an in vitro study is currently being performed using DCs.

Our study shows for the first time that gastric MALT lymphoma strains, especially cagPAI negative, can be distinguished from gastritis strains. This particular Lewis profile is probably representative of the adaptation of H. pylori during the micro-environmental changes that the bacterium encounters in the course of infection. Moreover, it could represent an adaptive mechanism to the host response that should be explored in vivo in a murine model of gastric MALT lymphoma, and especially on a long-term survival in the host and modulation of host immune responses (autoimmune antibody production, release of cytokines).

Materials and Methods

Bacterial strains

A subset of the French gastric MALT lymphoma strain collection provided by the French National Reference Center for Campylobacters and Helicobacters was included in this study: 40 strains from gastric MALT lymphoma patients (24 men and 16 women), mean age 58.4 (13.8)). For all these strains the cagPAI status and vacA genotypes have been previously published: 19 cagPAI (−) and 21 cagPAI (+) [4].

A selection of 39 strains isolated from chronic gastritis only patients (16 men and 23 women, mean age 48.3 (13.2)) were included as a population control. All of these strains were isolated from patients included in the Swedish Kalixanda study which was performed on a general adult population from northern Sweden. The strains included in this study were selected according to their cagPAI status (17 cagPAI (−) and 22 cagPAI (+)) in order to be comparable with the MALT strain collection [34].

LPS purification

All of the strains (previously obtained from single colonies) were defrosted on G plates before LPS extraction. Then H. pylori was grown in brucella broth supplemented with 5% fetal bovine serum and 1% IsoVitaleX Enrichment to exponential phase (OD600nm between 0.3 and 0.6). An equal amount of bacteria from each strain was harvested by centrifugation and washed once in PBS. The LPS from each bacterial pellet were extracted twice using a hot phenol protocol as already described [18]. After an overnight precipitation in ethanol and sodium acetate, the LPS were dried in air and resuspended in water.

Polyacrylamide gel electrophoresis and immunobloting

LPS extracts were analyzed by SDS/PAGE by using a 4–15% separating polyacrylamide gel and blotted onto a polyvinylidene difluoride membrane (Immun-Blot PVDF Membrane, Biorad, Hercules, CA). Mouse anti-Lex (MCA 1313, Serotec, dilution 1/500) and anti-Ley (BG-8, Signet Laboratories Inc., Dedham, MA, dilution 1/2000) were used as primary antibodies and horseradish peroxidase-conjugated goat anti-mouse IgM (Start 86P, Serotec, dilution 1/1000) as a secondary antibody. Membranes were incubated with antibodies and developed with enhanced chemiluminescence (ECL) (Amersham Pharmacia Biosciences, Buckinghamshire, UK.) as already described [18], [25], [35]. The LPS extraction for Lex and Ley negative strains was also verified on SDS/PAGE gels stained with silver.

PCR and sequencing

H. pylori DNAs were purified with DNeasy Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations from bacterial pellets obtained from the same brucella broth as those used for LPS extraction. For gastritis strains, the vacA alleles (s and m regions) were detected by PCR as previously described [4], [36]. Finally, the 5′end parts of genes encoding FutA and FutB were amplified and sequenced for Lex and Ley negative gastritis and MALT strains identified in this study. The sequences of the primers used for futA and futB amplification and sequencing are indicated in Table 3.

thumbnail
Table 3. Sequences of the primers used to amplify and/or sequence futA and futB genes isolated from Helicobacter pylori gastric MALT lymphoma and chronic gastritis strains.

https://doi.org/10.1371/journal.pone.0007297.t003

Statistical methods

All analyses were conducted using the SAS 9.2 package (SAS Institute, Cary, NC). Correlations between genes were tested by the Spearman method. ORs with 95% CIs derived from unconditional logistic models were used to assess associations between Lewis antigens and disease status, and vacA genotypes and disease status, with adjustments for gender and age. Interaction effects between and among genotypes and Lewis antigens were tested by inclusion of product terms in regression models.

Acknowledgments

The authors wish to thank Helene Kling Bäckhed for technical support and for fruitful discussions.

Author Contributions

Conceived and designed the experiments: PL AS. Performed the experiments: PL. Analyzed the data: PL ZZ LE. Contributed reagents/materials/analysis tools: PL FM LE. Wrote the paper: PL AS FM LE.

References

  1. 1. IARC (1994) Schistosomes, liver flukes and Helicobacter pylori. in “Monographs on the evaluation of carcinogenic risks to humans” IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 61. : 1–241. Lyon, 7–14 June 1994.
  2. 2. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, et al. (1999) Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A 96: 12778–12783.
  3. 3. Koehler CI, Mues MB, Dienes HP, Kriegsmann J, Schirmacher P, et al. (2003) Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues. Mol Pathol 56: 36–42.
  4. 4. Lehours P, Menard A, Dupouy S, Bergey B, Richy F, et al. (2004) Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect Immun 72: 880–888.
  5. 5. Lehours P, Dupouy S, Bergey B, Ruskone-Foumestraux A, Delchier JC, et al. (2004) Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type. Gut 53: 931–937.
  6. 6. Lehours P, Megraud F (2005) Helicobacter pylori infection and gastric MALT lymphoma. Rocz Akad Med Bialymst 50: 54–61.
  7. 7. Ferreri AJ, Ernberg I, Copie-Bergman C (2009) Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med 265: 421–438.
  8. 8. Hussell T, Issacson PG, Crabtree JE, Spencer J (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342: 571–574.
  9. 9. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, et al. (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158: 962–967.
  10. 10. D'Elios MM, Amedei A, Manghetti M, Costa F, Baldari CT, et al. (1999) Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma. Gastroenterology 117: 1105–1112.
  11. 11. Rescigno M, Lopatin U, Chieppa M (2008) Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. Curr Opin Immunol 20: 669–675.
  12. 12. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, et al. (2004) Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 200: 979–990.
  13. 13. Suarez F, Lortholary O, Hermine O, Lecuit M (2006) Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107: 3034–3044.
  14. 14. Vandenbroucke-Grauls CM, Appelmelk BJ (1998) Helicobacter pylori LPS: molecular mimicry with the host and role in autoimmunity. Ital J Gastroenterol Hepatol 30: Suppl 3S259–260.
  15. 15. Kobayashi K, Sakamoto J, Kito T, Yamamura Y, Koshikawa T, et al. (1993) Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma. Am J Gastroenterol 88: 919–924.
  16. 16. Monteiro MA, Chan KHN, Rasko DA, Taylor DE, Zheng PY, et al. (1998) Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. J Biol Chem 273: 11533–11543.
  17. 17. Heneghan MA, McCarthy CF, Moran AP (2000) Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host Lewis phenotype and inflammatory response. Infect Immun 68: 937–941.
  18. 18. Nilsson C, Skoglund A, Moran AP, Annuk H, Engstrand L, et al. (2006) An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection. Proc Natl Acad Sci U S A 103: 2863–2868.
  19. 19. Moran AP (2008) Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr Res 343: 1952–1965.
  20. 20. Hynes SO, Moran AP (2000) Comparison of three serological methods for detection of Lewis antigens on the surface of Helicobacter pylori. FEMS Microbiol Lett 190: 67–72.
  21. 21. Wirth HP, Yang M, Karita M, Blaser MJ (1996) Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status. Infect Immun 64: 4598–4605.
  22. 22. Marshall DG, Hynes SO, Coleman DC, O'Morain CA, Smyth CJ, et al. (1999) Lack of a relationship between Lewis antigen expression and cagA, CagA, vacA and VacA status of Irish Helicobacter pylori isolates. FEMS Immunol Med Microbiol 24: 79–90.
  23. 23. Gonzalez-Valencia G, Munoz-Perez L, Morales-Espinosa R, Camorlinga-Ponce M, Munoz O, et al. (2008) Lewis antigen expression by Helicobacter pylori strains colonizing different regions of the stomach of individual patients. J Clin Microbiol 46: 2783–2785.
  24. 24. Broutet N, Moran A, Hynes S, Sakarovitch C, Megraud F (2002) Lewis antigen expression and other pathogenic factors in the presence of atrophic chronic gastritis in a European population. J Infect Dis 185: 503–512.
  25. 25. Skoglund A, Backhed HK, Nilsson C, Bjorkholm B, Normark S, et al. (2009) A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization. PLoS One 4: e5885.
  26. 26. Ferreira-Chagas B, Lasne G, Dupouy S, Gallois A, Morgner A, et al. (2007) In Vitro Proinflammatory Properties of Helicobacter pylori Strains Causing Low-Grade Gastric MALT Lymphoma. Helicobacter 12: 616–617.
  27. 27. Moran AP (1999) Helicobacter pylori lipopolysaccharide-mediated gastric and extragastric pathology. J Physiol Pharmacol 50: 787–805.
  28. 28. Wang G, Rasko DA, Sherburne R, Taylor DE (1999) Molecular genetic basis for the variable expression of Lewis Y antigen in Helicobacter pylori: analysis of the alpha (1,2) fucosyltransferase gene. Mol Microbiol 31: 1265–1274.
  29. 29. Wang G, Ge Z, Rasko DA, Taylor DE (2000) Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol Microbiol 36: 1187–1196.
  30. 30. Mueller A, O'Rourke J, Grimm J, Guillemin K, Dixon MF, et al. (2003) Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A 100: 1292–1297.
  31. 31. O'Rourke JL (2008) Gene expression profiling in Helicobacter-induced MALT lymphoma with reference to antigen drive and protective immunization. J Gastroenterol Hepatol 23: Suppl 2S151–156.
  32. 32. Greiner A, Knorr C, Qin YF, Sebald W, Schimpl A, et al. (1997) Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD4O-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 150: 1583–1593.
  33. 33. Fukui T, Okazaki K, Tamaki H, Kawasaki K, Matsuura M, et al. (2004) Immunogenetic analysis of gastric MALT lymphoma-like lesions induced by Helicobacter pylori infection in neonatally thymectomized mice. Lab Invest 84: 485–492.
  34. 34. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, et al. (2004) Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 39: 1280–1288.
  35. 35. Nilsson C, Skoglund A, Moran AP, Annuk H, Engstrand L, et al. (2008) Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases. PLoS One 3: e3811.
  36. 36. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, et al. (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori - Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270: 17771–17777.